# Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations

> **NCT03082352** · PHASE1 · UNKNOWN · sponsor: **Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited** · enrollment: 30 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BF-Metoprolol Tablet 100mg
- **DRUG:** Betaloc Tablet 100mg

## Key facts

- **NCT ID:** NCT03082352
- **Lead sponsor:** Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03082352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03082352, "Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03082352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*